Junior doctors are failing to recognise ST elevation, and there are wide variations in practice, suggests UK research. Given that junior doctors usually decide who should be given thrombolytic therapy, the finding is of some concern, and perhaps the time has come for a consensus to be reached,...
The first electrocardiogram (ECG) post-ROSC was assessed for STE-aVR, defined as 鈮 1 mm ST-segment elevation at the J point, measured by two trained assessors. Multivariable logistic regression was used to analyze the association between STE-aVR and outcomes (in-hospital mortality and poor ...
Long-term Outcomes of Primary Percutaneous Coronary Intervention with Second-generation Drug-eluting Stents in ST-elevation Myocardial Infarction Patients ... Background: The ST-segment elevation myocardial infarction (STEMI) patients due to stent thrombosis (ST) remain a therapeutic challenge for a ...
results and at least 4 of the following criteria: concavity of the initial up-sloping portion of the ST-segment; notching or slurring of the J point; symmetric, concordant, predominant T waves; J-point elevation and widespread distribution of the electrocardiographic abnormality; or temporal ...
upper reference limit in patients presenting with symptoms of ischemia together with new ST elevation at the J-point in two contiguous leads with the cut-off points: 0.2 mV in men or 0.15 mV in women in leads V2-V3 and/or 0.1 mV in other leads or new left bundle-branch block [14]....
ContextPatients with unstable angina/non–ST-segment elevation myocardial infarction (MI) (UA/NSTEMI) present with a wide spectrum of risk for death and
(i) new ST-segment elevation at theJpoint in two contiguous leads with the cut-off value greater than 0.1 mV in all leads other than V2 or V3 and (ii) in leads V2-V3, a cut-off value of ≥0.2 mV in men aged ≥40 years, ≥0.25 in men aged <40 years, or ≥0.15...
Background:Primary percutaneous coronary intervention ([PCI], percutaneous transluminal coronary angioplasty+stenting) for ST-segment elevation myocardial infarction (STEMI) is regarded as superior to fibrinolysis even if it means that patients need to be transferred from one center to another to undergo...
Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial JAMA, 297 (2007), pp. 1775-1783 CrossrefView in ScopusGoogle Scholar 14 N.G. Morgenthaler, J. Struck, C. Alonso, A. Bergmann Assay for the...
Objective To evaluate the short-term safety of ticagrelor when compared with clopidogrel in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy. Design, Setting and Participants We conducted a multicenter, randomized, open-label with blinded end point adjudication trial that ...